Onset of multiple sclerosis associated with anti-TNF therapy
NL Sicotte, RR Voskuhl - Neurology, 2001 - AAN Enterprises
Neurology, 2001•AAN Enterprises
Therapies aimed at inhibiting tumor necrosis factor (TNF), a proinflammatory cytokine
implicated in autoimmune disease are effective, especially for rheumatoid arthritis. We report
a patient with new onset MS closely associated with the initiation of anti-TNF therapy for
juvenile rheumatoid arthritis. It is possible that the inhibition of TNF triggered MS in this
individual.
implicated in autoimmune disease are effective, especially for rheumatoid arthritis. We report
a patient with new onset MS closely associated with the initiation of anti-TNF therapy for
juvenile rheumatoid arthritis. It is possible that the inhibition of TNF triggered MS in this
individual.
Therapies aimed at inhibiting tumor necrosis factor (TNF), a proinflammatory cytokine implicated in autoimmune disease are effective, especially for rheumatoid arthritis. We report a patient with new onset MS closely associated with the initiation of anti-TNF therapy for juvenile rheumatoid arthritis. It is possible that the inhibition of TNF triggered MS in this individual.
American Academy of Neurology